Schedule 13D ownership disclosure

EDESA BIOTECH INC

Common Shares, no par value per share · CUSIP: 27966L306

Event date: 2026-02-26

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Pardeep Nijhawan Medicine Professional Corporation

    Shares: 1,133,676.00 · Class: 11.9%

  • The Digestive Health Clinic Inc.

    Shares: 32,013.00 · Class: 0.4%

  • 1968160 Ontario Inc.

    Shares: 53,104.00 · Class: 0.6%

  • The New Nijhawan Family Trust 2015

    Shares: 32,609.00 · Class: 0.4%

  • Pardeep NijhawanReported CIK 0001777962

    Shares: 2,040,785.00 · Class: 19.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001171843-26-001269
Form type
SCHEDULE 13D/A
Filer
Edesa Biotech, Inc.
CIK
CIK 1540159
Filed
Mar 02, 2026
Reporting period
Feb 26, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub